Gamma Knife in Ramat Gan typically costs from $21,500 to $33,500. The final price depends on case complexity and necessary pre-operative imaging. Patients save around 76% compared to the US, where this procedure costs $70,000 on average. The cost usually includes the procedure, 1-2 days of hospitalization, and the stereotactic frame application.
Bookimed Expert Insight: Ramat Gan is the primary neuro-oncology hub in Israel, housing the largest hospital in the Middle East. High-volume centers here offer superior value by providing access to world-ranked specialists included in Forbes' Top Doctors. Prof. Zvi Cohen at Sheba Medical Center, for example, combines US fellowship expertise with advanced intraoperative MRI technology. This concentration of research-led care ensures patients receive academic-grade treatment without the diagnostic delays common in smaller cities.
| Israel | Turkey | Austria | |
| Gamma Knife | from $13,800 | from $6,300 | from $32,000 |
| Gamma Knife for brain tumor | from $19,500 | from $4,750 | from $25,000 |
| Gamma-knife for spinal tumor | - | from $6,500 | from $12,500 |
No hidden fees – just official clinic prices. Pay at the clinic for Gamma Knife upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Gamma Knife and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Gamma Knife journey.
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Gamma Knife Surgery
Day 4 - Post-Operation
Week 1-4 - Rehabilitation
Note: Each patient"s recovery timeline may vary based on individual health conditions and the complexity of the Gamma Knife surgery.
Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.
He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.